1. Home
  2. TFSL vs AXSM Comparison

TFSL vs AXSM Comparison

Compare TFSL & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TFSL
  • AXSM
  • Stock Information
  • Founded
  • TFSL 1938
  • AXSM 2012
  • Country
  • TFSL United States
  • AXSM United States
  • Employees
  • TFSL N/A
  • AXSM N/A
  • Industry
  • TFSL Savings Institutions
  • AXSM Biotechnology: Pharmaceutical Preparations
  • Sector
  • TFSL Finance
  • AXSM Health Care
  • Exchange
  • TFSL Nasdaq
  • AXSM Nasdaq
  • Market Cap
  • TFSL 3.8B
  • AXSM 4.4B
  • IPO Year
  • TFSL 2007
  • AXSM 2015
  • Fundamental
  • Price
  • TFSL $13.05
  • AXSM $95.84
  • Analyst Decision
  • TFSL Hold
  • AXSM Strong Buy
  • Analyst Count
  • TFSL 2
  • AXSM 14
  • Target Price
  • TFSL $14.00
  • AXSM $124.57
  • AVG Volume (30 Days)
  • TFSL 213.3K
  • AXSM 405.5K
  • Earning Date
  • TFSL 10-24-2024
  • AXSM 11-04-2024
  • Dividend Yield
  • TFSL 8.55%
  • AXSM N/A
  • EPS Growth
  • TFSL N/A
  • AXSM N/A
  • EPS
  • TFSL 0.28
  • AXSM N/A
  • Revenue
  • TFSL $305,488,000.00
  • AXSM $291,489,000.00
  • Revenue This Year
  • TFSL N/A
  • AXSM $42.50
  • Revenue Next Year
  • TFSL N/A
  • AXSM $69.28
  • P/E Ratio
  • TFSL $48.14
  • AXSM N/A
  • Revenue Growth
  • TFSL N/A
  • AXSM 59.73
  • 52 Week Low
  • TFSL $10.97
  • AXSM $55.02
  • 52 Week High
  • TFSL $15.25
  • AXSM $98.40
  • Technical
  • Relative Strength Index (RSI)
  • TFSL 46.36
  • AXSM 64.19
  • Support Level
  • TFSL $13.04
  • AXSM $89.24
  • Resistance Level
  • TFSL $13.55
  • AXSM $96.71
  • Average True Range (ATR)
  • TFSL 0.30
  • AXSM 3.66
  • MACD
  • TFSL 0.00
  • AXSM 0.02
  • Stochastic Oscillator
  • TFSL 44.12
  • AXSM 87.05

About TFSL TFS Financial Corporation

TFS Financial Corp is the holding company for the Third Federal Savings and Loan Association of Cleveland. The company's ownership in the savings and loan association is its primary business activity. The association's principal business consists of originating and servicing residential real estate mortgage loans and attracting retail savings deposits. It does so by offering products with competitive rates and yields. The company also operates Third Capital, a wholly owned subsidiary that serves as a holding company or as an investor in vehicles such as private equity funds. Third Capital has interests in lease transactions of commercial buildings, title agencies providing escrow and settlement services, and reinsurance of private mortgage insurance on residential loans.

About AXSM Axsome Therapeutics Inc.

Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.

Share on Social Networks: